The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

The invention relates to a handling device (1) for medical technology, with a main body part (2) and a front wall (5) which define a receiving space (6). A cannula (10) protrudes with its proximal cannula end (11) into the receiving space (6). A hose-like sleeve (12) is held with its distal sleeve end (13) on at least one holding element (16) of the holding device (8), which holding element (16) is formed or arranged directly on the front wall (5). The holding element (16) bears externally on the sleeve (12) in a contact area. Moreover, the invention also relates to a method for producing a handling device (1) of this type.

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.

Blood collection assemblies with safety features are disclosed. The assemblies have a housing for receiving a vacutainer, which has a septum that penetrates a sharp needle tip. The disclosed assemblies further have a shield for covering the other end of the needle following use to prevent accidental contact with the distal needle tip. The shield is spring loaded so that the spring force moves the shield over the needle. The shield can be secured or held in an initial position and allowed to move to cover the needle upon actuation or activation of an activator unit.

Needle support assembly for a venous blood collection device with evacuated vial, comprising a support body having a coupling seat for a vein needle and coupling seat for a vial needle. The support body is provided with an inner chamber having an entrance and an exit. The support body is made at least partially in transparent or semi-transparent material to permit the visualization of the blood flow. The inner chamber has a mean cross-section greater than the cross-sections of both the coupling seats and is divided into compartments communicating with each other which define one or more channels for the blood flow from the entrance to the exit. Each channel defines a path for the blood which moves away from the entrance to the exit. Each channel defines a path for the blood which moves away from the straight line connecting the entrance and the exit and has a smaller cross-section than the mean cross-section of the inner chamber.

A sampling device for a sampling container. A pair of elongate flexible arms extend from a side wall away from a bottom end. The arms being oppositely located across a base chamber. A lower member has a flange and an aperture. A collar extends from the flange and is adapted to retain an end of a spring. An elongate cover has a first end and a second end. The first end being adapted in use to connect to a base and the second end being adapted in use to connect to an upper member. The upper and lower members are adapted to move along the axis by the positioning of a sampling container in the sampling chamber and the application of a force towards a base, permits a needle or blood bag tube located within a connector to discharge liquid into a sampling container.

A device and kit and method for controlling coagulation in a blood sample. The coagulation controlling agent is at least one of citrate, a protamine salt, its homologs and derivatives, benzamidine, or para-aminobenzamidine. Additives such as water soluble polymers and sugars are also contemplated. The device and kit comprise a container that contains an effective amount of thrombin and a coagulation controlling agent. The method combines thrombin and a coagulation controlling agent to stabilize thrombin or accelerate its activity in a blood sample.

The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.